UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056085 |
|---|---|
| Receipt number | R000064087 |
| Scientific Title | Exploratory study on the effects of short-chain aldehydes on liver tissue |
| Date of disclosure of the study information | 2024/11/07 |
| Last modified on | 2025/11/19 15:02:27 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Exploratory study on the effects of short-chain aldehydes on liver tissue
Acronym
Exploratory study on the effects of short-chain aldehydes on liver tissue
Scientific Title
Exploratory study on the effects of short-chain aldehydes on liver tissue
Scientific Title:Acronym
Exploratory study on the effects of short-chain aldehydes on liver tissue
Region
| Japan |
Condition
Condition
Liver disease
Classification by specialty
| Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Explore the effects of short-chain aldehydes on liver tissue
Basic objectives2
Others
Basic objectives -Others
Elucidate the impact of glyceraldehyde, produced in the metabolic pathways of glucose and fructose, on the pathogenesis of MASLD
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
plasma glyceraldehyde
Key secondary outcomes
-Histological severity of steatotic liver disease
-Glyceraldehyde and methylglyoxal content of liver tissue
-Glucose tolerance (blood glucose and HbA1c)
-Presence of short-chain aldehydes and DNA adducts in liver tissue
-Markers of liver fibrosis
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Individuals aged 18 and older hospitalized for scheduled liver resection
Key exclusion criteria
Individuals diagnosed with hepatitis B or hepatitis C.
Individuals taking oral steroid medications.
Individuals scheduled for liver transplantation.
Target sample size
35
Research contact person
Name of lead principal investigator
| 1st name | Kaori |
| Middle name | |
| Last name | Ikeda |
Organization
Kyoto University Hospital
Division name
Institute for Advancement of Clinical and Translational Science/Department of Diabetes, Endocrinology and Nutrition
Zip code
606-8501
Address
54 Shogoinkawahara-cho, Sakyo-ku,Kyoto-shi,Kyoto
TEL
0757513560
krikeda@kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoko |
| Middle name | |
| Last name | Ueba |
Organization
Graduate School of Medicine, Kyoto University
Division name
Department of Diabetes, Endocrinology and Nutrition
Zip code
606-8501
Address
54 Shogoinkawahara-cho, Sakyo-ku,Kyoto-shi,Kyoto
TEL
0757513560
Homepage URL
yokoueba@kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
Kyoto University Hospital
Institute
Department
Personal name
Kaori Ikeda
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Kyoto Katsura Hospital
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kyoto University Graduate School and Faculty of Medicine, Ethics Committee
Address
Yoshida-Konoe-cho, Sakyo-ku, Kyoto
Tel
0757534680
ethcom@kuhp.kyoto-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
京都大学医学部附属病院（京都府）、京都桂病院（京都府）
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 11 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2024 | Year | 10 | Month | 04 | Day |
Date of IRB
| 2024 | Year | 10 | Month | 25 | Day |
Anticipated trial start date
| 2024 | Year | 11 | Month | 11 | Day |
Last follow-up date
| 2026 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluate the relationship between liver fat content and the levels of short-chain aldehydes in blood and liver tissue.
Management information
Registered date
| 2024 | Year | 11 | Month | 07 | Day |
Last modified on
| 2025 | Year | 11 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064087
